BENJAMIN BOERNER: Open Payments
NPI 1568089043 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,326 in 97 payments from 14 companies in 2025. Trend: 2023 $1,217 · 2024 $1,351 · 2025 $2,326
Food & beverage: $2,218Education: $107
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 24 | $618 |
| AstraZeneca Pharmaceuticals LP | 13 | $409 |
| Novartis Pharmaceuticals Corporation | 11 | $273 |
| GlaxoSmithKline, LLC. | 14 | $248 |
| Regeneron Healthcare Solutions, Inc. | 9 | $184 |
| CSL Behring | 6 | $115 |
| Optinose US, Inc. | 5 | $110 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $96 |
| Grifols USA, LLC | 2 | $60 |
Products named: DUPIXENT, FASENRA, NUCALA, Rhapsido, Hizentra, Xhance, NEFFY, TEZSPIRE.
Industry payments across OH — which companies pay providers there.
